1. |
IGFBP-1: A Metabolic Signal Associated With Exercise - Induced
Amenorrhoea. PJ Jenkins, X Ibanez-Santos, J Holly, A Cotterill, L Perry, R Wolman, M
Harries, A Grossman
Neuroendocrinology 1993; 57: 600-603 |
2. |
The Control of the GnRH Pulse Generator With Respect to Opioid and Nutritional
Cues. PJ Jenkins and A Grossman Human Reproduction 1993; 8:154-161 |
3. |
Adrenocorticotrophin - independent Unilateral Macronodular Adrenal Hyperplasia and
Coexistant Myelolipoma: An Unusual Cause of Cushing's Syndrome. PJ Jenkins, SL Chew, DG
Lowe, RH Reznek, JAH Wass Clinical Endocrinology 1994 41: 827-830 |
4. |
Gender Differences in Incidence of Idiopathic Fistula-in-ano Are Not Explained by
Circulating Sex Hormones. PJ Lunniss, PJ Jenkins , GM Besser, LA Perry,
Phillips RKS International Journal of Colorectal Disease 1995 10 25-28 |
5. |
The Long-term Outcome After Adrenalectomy and Prophylactic Pituitary Radiotherapy
for Cushing's Disease
PJ Jenkins , PJ Trainer, PN Plowman, WS Shand, JAH Wass, AB Grossman, GM Besser
Journal of Clinical Endocrinology and Metabolism 1995 80 165-171
|
6. |
Lymphocytic Hypophysitis: Unusual Features of a Rare Disorder
PJ Jenkins , SL Chew, DG Lowe, M Charlesworth, GM Besser, JAH Wass Clinical
Endocrinology 1995 42 529-534
|
7. |
Are Activating Mutations of the Adrenocorticotropin Receptor Involved in Adrenal
Cortical Neoplasia? K Light, PJ Jenkins , A Weber, C Perrett, A Grossman, M
Pistotrello, SL Asa, RN Clayton, AJL Clark Life Sciences 1995 56 1523-1527
|
8. |
The Roles of Gallbladder Emptying and Intestinal Transit in the Pathogenesis of
Octreotide-Induced Gallbladder Stones. SH Hussaini, SP Pereira, C Kennedy, PJ Jenkins
, GM Murphy, JAH Wass, RH Dowling Gut 1996 38 775-783 |
9. |
Oral Prednisolone Supplementation Abolishes the Acute Adverse Effects Following
Initiation of Depot Bromocriptine Therapy
PJ Jenkins , A Jain, SL Jones, GM Besser, AB Grossman Clinical Endocrinology
1996 45 447-452** ** Selected for the 1998 Year Book of Endocrinology (Ed: Dr
M Molitch; publishers Mosby-Year Book Inc)
|
10. |
Outcome of Transsphenoidal Surgery for Acromegaly Using Strict Criteria for
Surgical Cure R Sheaves, PJ Jenkins , P Blackburn , AH Huneidi, F Afshar , AB
Grossman, GM Besser, JAH Wass Clinical Endocrinology 1996 45 407-413 |
11. |
Intracardiac Metastases from Neuroendocrine Tumours
W Drake, PJ Jenkins , RR Phillips, DG Lowe, AB Grossman, GM Besser, JAH Wass
Clinical Endocrinology 1997 46 517-522 |
12. |
Acromegaly, Colonic Polyps and Carcinoma
PJ Jenkins , PD Fairclough, T Richards, DG Lowe, J Monson , AB Grossman,
JAH Wass, GM Besser Clinical Endocrinology 1997 47 17-22 |
13. |
Metastatic Parathyroid Carcinoma in the MEN 2A Syndrome
PJ Jenkins , M Satta, M Simmgen, WM Drake, C Williamson, DG Lowe, K Britton, SL
Chew, RV Thakker, GM Besser Clinical Endocrinology 1997 47 747-751
|
14. |
Cancer in Acromegaly
PJ Jenkins
Trends in Endocrinology and Metabolism 1998 9 :360-366
|
15. |
Prolonged Large Bowel Transit Increases Serum Deoxycholic Acid - a Risk Factor for
Octreotide-Induced Gallbladder Stones MJ Veysey, LA Thomas, AI Mallet, PJ Jenkins
, GM Besser, JAH Wass, GM Murphy, RH Dowling Gut 1999 44 675-681
|
16. |
The Influence of Plasma on Basal and ACTH-stimulated in vitro Adrenocortical
Steroidogenesis
PJ Jenkins , TA Cross, LA Perry, S Medbak , AJL Clark, GM Besser Journal of
Endocrinology 1999 162 155-161
|
17. |
Growth Hormone and Exercise
PJ Jenkins
Clinical Endocrinology 1999 50 683-689
|
18. |
Colorectal Neoplasia in Acromegaly
PJ Jenkins , GM Besser, PD Fairclough Gut 1999 44 585-587
|
19. |
Adrenal Enlargement and Failure of Suppression of Circulating Cortisol by
Dexamthasone in Patients with Malignancy
PJ Jenkins , SA Sohaib, PJ Trainer, TA Lister, AJ Clark, GM Besser, RH Reznek
British Journal of Cancer 1999 80 1815-1819
|
20. |
Detection of GH Doping
P.J. Jenkins
The Lancet 1999 353 1532
|
21. |
Respiratory Muscle Strength in Cushing's Syndrome
GH Mills, D Kyroussis, P Jenkins , C Hamnegard , MI Polkey, JAH Wass, GM
Besser, J Moxham, M Green American Journal of Respiratory and Critical Care Medicine 1999
160 1762-1765 |
22. |
Colorectal Neoplasia in Acromegaly
PJ Jenkins , PD Fairclough, GM Besser Gut 1999
|
23. |
Menstrual Irregularity in Women with Acromegaly GA Kaltsas, JJ Mukherjee,
PJ Jenkins , MA Satta, N Islam, JP Monson, GM Besser, AB Grossman Journal of
Clinical Endocrinology and Metabolism 1999 84 2731-2735 |
24. |
Hypothalamo-Pituitary Abnormalities in Adult Patients with Langerhan's Cell
Histiocytosis: Clinical, Endocrinological and Radiological Features and Response to Treatment
GA Kaltsas, TB Powles, J Evanson, PN Plowman, JE Drinkwater, PJ Jenkins , JP
Monson, GM Besser, AB Grossman Journal of Clinical Endocrinology and Metabolism 2000
85 1370-1376 |
25. |
Low Expression of the Cell Cycle Inhibitor p27 in Normal Corticotroph Cells,
Corticotroph Tumours and Malignant Pituitary Tumours K. Lidhar, M. Korbonits, S. Jordan, Z.
Khalimova, G. Kaltsas, X. Lu, R.N. Clayton, P.J. Jenkins , J.P. Monson, G.M
Besser, D.G. Lowe, A.B. Grossman Journal of Clinical Endocrinology and Metabolism 1999
84 3823-3830 |
26. |
Alterations in Serum Protein Levels in Patients with Cushing's Syndrome Before and
After Successful Treatment P. Putignano, G.A. Kaltsas, M. Korbonits, P.J. Jenkins
, J.P. Monson, G.M. Besser, A.B. Grossman Journal of Clinical Endocrinology and
Metabolism 2000 85 3309-3312 |
27. |
IGF-I and the Development of Colorectal Neoplasia in Acromegaly
P.J. Jenkins , V. Frajese, A-M. Jones, C. Camacho-Hubner, D.G. Lowe, P.D.
Fairclough, S.L. Chew, A.B. Grossman, J.P. Monson, G.M. Besser Journal of Clinical
Endocrinology and Metabolism 2000 85 3218-3221
|
28. |
The Pathobiology of Median Neuropathy in Acromegaly
PJ Jenkins , S.A. Sohaib, S Akker, R.R. Phillips, K. Spillane, J.A.H. Wass, J.P.
Momson, A.B. Grossman, G.M. Besser, R.H. Reznek Annals of Internal Medicine 2000 133
197-201
|
29. |
Uterine Leiomyomata in Women with Acromegaly
G Kaltsas, PJ Jenkins, J. Webb, JP Monson, GM Besser, A Grossman Journal of
Clinical Endocrinology and Metabolism 85 2000 1347 |
30. |
The Use of Long-acting Somatostatin Analogues in Acromegaly
P.J. Jenkins
Growth Hormone and IGF Research 2000 10 Suppl B: S111-114
|
31. |
Acromegaly and Colon Cancer
P.J. Jenkins
Growth Hormone and IGF Research 2000 10 Suppl A:S35-S36
|
32. |
Optimal Dosage Interval for Depot Somatostatin Analogue Therapy in Acromegaly
Requires Individual Titration
P.J.Jenkins, S. Akker, S.L. Chew, G.M. Besser, J.P. Monson, A.B. Grossman
Clinical Endocrinology 2000 53 719-724
|
33. |
Sustained Reduction in Circulating Cholesterol in Adult Hypopituitary Patients
Given Low Dose Titrated Growth Hormone Replacement Therapy: a Two Year Study
D. Florakis, V. Hung, G. Kaltsas, D. Coyte, P.J. Jenkins, S.L. Chew, A.B. Grossman, G.M.
Besser, J.P. Monson
Clinical Endocrinology 2000 53 453-462 |
34. |
Comparison of Somatostatin Analog and Metaiodobenzylguanidine (MIBG) Radionuclides
In The Diagnosis and Localisation of Advanced Neuroendocrine Tumors
G. Kaltsas, M. Korbonits, E. Heintz, J.J. Mukherjee, P.J. Jenkins, S.L. Chew, J.P. Monson,
G.M. Besser, K.E. Britton, A.B. Grossman
Journal of Clinical Endocrinology and Metabolism 2001 86 895-902 |
35. |
Predictors of the Outcome of Surgical Treatment in Acromegaly and the Value of the
Mean Growth Hormone Day Curve in Assessing Postoperative Disease Activity
GA Kaltsas, AM Isidori, D Florakis, PJ Trainer, C Camacho-Hubner, F Afshar, I Sabin, PJ
Jenkins, SL Chew, JP Monson, GM Besser, AB Grossman
Journal of Clinical Endocrinology and Metabolism 2001 86 1656-1652 |
36. |
Increased Levels of Insulin-like Growth Factor Binding Protein-2 in Serum and
Tumours and Sera From Patients with Colonic neoplasia with and without Acromegaly
F Miraki-Moud, PJ Jenkins, PD Fairclough, S Jordan, AM Jones, DG Lowe, JP Monson, AB
Grossman, GM Besser, C Camacho-Hubner
Clinical Endocrinology 2001 54 499-508 |
37. |
Acromegaly and Cancer: A Problem
PJ Jenkins and GM Besser
Journal of Clinical Endocrinology and Metabolism 2001 86 2935-2941
|
38. |
The Growth Hormone/ Insulin-like Growth Factor-I Axis and Colorectal Cancer
SA Bustin and PJ Jenkins
Trends in Molecular Medicine 2001 7 447-454 |
39. |
Colorectal neoplasia in acromegaly
PJ Jenkins and PD Fairclough
Clinical Endocrinology 2001 55 727-730
|
40. |
Colonic Transit Influences Deoxycholic Acid Kinetics
M.J Veysey, L.A. Thomas, A.I. Mallet, PJ Jenkins, GM Besser, GM Murphy, RH Dowling
Gastroenterology 2001 121 812-822 |
41. |
Effects of cisapride on gall bladder emptying, intestinal transit, and serum
deoxycholate: a prospective, randomised, double blind, placebo controlled trial
MJ Veysey, P Malcolm, AI Mallet, PJ Jenkins, GM Besser, GM Murphy, RH Dowling
Gut 2001 49 828-834 |
42. |
Treatment of metastatic carcinoid tumours, phaeochromocytoma, paraganglioma and
medullary carcinoma of the thyroid with (131)I-meta- iodobenzylguanidine [(131)I-mIBG]
Mukherjee,J.J.; Kaltsas,G.A.; Islam,N.; Plowman,P.N.; Foley,R.; Hikmat,J.;
Britton,K.E.;PJ Jenkins; Chew,S.L.;Monson,J.P.;Besser,G.M.;Grossman,A.B.
Clinical Endocrinology 2001 55 47-60 |
43. |
Growth hormone and exercise: physiology, use and abuse
PJ Jenkins
Growth Hormone and IGF-I Research 2001 11 (suppl A) S71-77
|
44. |
Down-regulation of 25-hydroxyvitamin D-1-a-hydroxylase mRNA in the normal colon of
patients with colorectal cancer.
Ogunkolade,BW, Boucher, BJ, Fairclough,PD, Hitman, GA, Dorudi S, Jenkins PJ, Bustin SA.
The Lancet 2002 359 1831-1832 |
45. |
Growth hormone replacement does not increase serum prostate-specific antigen in
hypopituitary men over 50 years
CW le Roux, PJ Jenkins, SL Chew, C Camacho-Hubner, AB Grossman, GM Besser, JP Monson
European Journal of Endocrinology 2002 147 1-5 |
46. |
Expression of the growth hormone/ IGF-I axis influences angiogenesis in colorectal
cancer
SA Bustin, W Ogunkolade, S Patel, S Khalaf, R Feakins S Dorudi, PJ Jenkins
Tumour Biology 2002 23 130-138 |
47. |
Doping in Sport
PJ Jenkins
The Lancet 2002 360 No 9327 99-100
|
48. |
The mRNA expression of cyclo-oxygenase-2 (COX-2) and vascular endothelial growth
factor (VEGF) in human breast cancer
K Kirkpatrick, W Ogunkolade, A Elkak, S Bustin, P Jenkins, M Ghilchik, K Mokbel.
Curr.Med.Res.Opin.2002 18 237-241 |
49. |
Neurosurgical treatment of Nelson’s syndrome
PA Kelly, G Samandouras, AB Grossman, F Afshar, GM Besser and PJ Jenkins
Journal of Clinical Endocrinology and Metabolism 2002 87 5465-5469 |
50. |
Screening guidelines for colorectal cancer and polyps in patients with
acromegaly
PJ Jenkins and PD Fairclough
Gut 2002 51 (suppl 5) V13-14
|
51. |
The GH/IGF-I axis and breast cancer.
C Laban, SA Bustin and PJ Jenkins
Trends in Endocrine and Metabolism 2003 14 28-34 |
52. |
hTERT expression in human breast cancer and non-cancerous breast tissue:
correlation with tumour stage and c-Myc expression
Kirkpatrick KL, Ogunkolade W, Elkak AE, Bustin S, Jenkins P, Ghilchick M, Newbold
RF, Mokbel K
Breast Cancer Research And Treatment 2003 77 (3): 277-284 |
53. |
The value of the low-dose dexamethasone suppression test in the differential
diagnosis of hyperandrogenism in women.
Kaltsas,G.A.; Isidori,A.M.; Kola,B.P.; Skelly,R.H.; Chew,S.L.; Jenkins,P.J.;
Monson,J.P.; Grossman,A.B.; Besser,G.M.
J.Clin.Endocrinol.Metab 2003 88 2634-26 |
54. |
IGF-1 levels, leg extensor power and physical performance after proximal femoral
fracture.
Barber M, Braid V, Gilmore D, Grant SJ, Camacho-Hubner C, Jenkins PJ et al. Age
Ageing 2003; 32(6):678-680. |
55. |
Modulation of Cortisol Metabolism during Treatment of Acromegaly Is Independent of
Body Composition and Insulin Sensitivity.
Frajese,G.V.; Taylor,N.F.; Jenkins,P.J.; Besser,G.M.; Monson,J.P.
Hormone Research 2004 61 246-251 |
56. |
Predicting therapeutic response and degree of pituitary tumour shrinkage during
treatment of acromegaly with octreotide LAR.
P.J. Jenkins, M. Emery, S.J. Howling, J. Evanson, G.M. Besser, J.P. Monson
Hormone Research 2004 62 227-232
|
57. |
Evidence for a link between IGF-I and cancer
P.J.Jenkins and S.A.Bustin
European Journal of Endocrinology 2004 151 S17-22
|
58. |
Acromegaly and Cancer
P.J.Jenkins
Hormone Research 2004 62 (suppl 1) 108-115
|
59. |
Differential Expression of IGFBP-3 in Normal and Malignant Colon and its Influence
on Apoptosis
P.J. Jenkins, S. Khalaf, W. Ogunkolade, K. McCarthy, T. David, R.E. Hands, D. Davies, and
S.A. Bustin
Endocrine Related Cancer 2005 12 891-901
|
60. |
Clinical and biochemical characteristics of
adrenocorticotropin-secreting macroadenomas. Woo YS, Isidori AM, Wat WZ, Kaltsas GA, Afshar
F, Sabin I, Jenkins PJ, Monson JP, Besser GM, Grossman AB. J Clin Endocrinol
Metab. 2005 Aug;90(8):4963-9.
|
61. |
The Ectopic Acth Syndrome: Clinical Features, Diagnosis, Management And Long- Term
Follow-Up.
Isidori,A.M.; Kaltsas,G.A.; Pozza,C.; Frajese,V.; Newell-Price,J.; Reznek,R.H.;
Jenkins,P.J.; Monson,J.P.; Grossman,A.B.; Besser,G.M.
J.Clin.Endocrinol.Metab 2005 |
62. |
Clinical and biochemical characteristics of adrenocorticotropin-secreting
macroadenomas
Woo,Y.S.; Isidori,A.M.; Wat,W.Z.; Kaltsas,G.A.; Afshar,F.; Sabin,I.; Jenkins,P.J.;
Monson,J.P.; Besser,G.M.; Grossman,A.B.
J.Clin.Endocrinol.Metab 2005 90 4963-4969 |
63. |
Does Growth Hormone Cause Cancer?
PJ Jenkins, A Mukherjee and SM Shalet
Clinical Endocrinology 2006 64 115-121
|
64. |
Conventional Pituitary Irradiation is Effective in Lowering Serum Growth Hormone
and Insulin-Like Growth Factor-I in Patients with Acromegaly
P.J. Jenkins, P. Bates, M.N. Carson, P.M. Stewart, J.A.H. Wass on behalf of the UK National
Acromegaly Register Study Group
J.Clin.Endocrinol.Metab 2006 91 1239-1245
|
65. |
Cyclo-oxygenase-2 (COX-2) mRNA expression and hormone receptor status in breast
cancer.
K. McCarthy, S. Bustin, C. Laban, W. Ogunkolade, S Khalaf, R. Carpenter and
P.J. Jenkins.
European Journal of Surgical Oncology 2006 Sep;32(7):707-9.
|
66. |
Screening Guidelines for Colorectal Cancer and Polyps in Patients with
Acromegaly
PJ Jenkins and PD Fairclough. Gut 2002; 51:v13-v14
|
67. |
Extended silencing of the IGF-I receptor gene signalling in MCF-7 cells by
serialtransfection with siRNA.
C. McVittie, S.Khalaf, W. Ogunkolade, V.M. Macaulay, R. Carpenter, S.A. Bustin,
P.J.Jenkins. Analytical Biochemistry 2004 |
68. |
The management of
differentiated thyroid cancer using 123I for imaging to assess the need for 131I therapy.
Ali N, Sebastian C, Foley RR, Murray I, Canizales AL, Jenkins PJ, Drake WM,
Plowman PN, Besser GM, Chew SL, Grossman AB, Monson JP, Britton KE.
Nucl Med Commun. 2006 Feb;27(2):165-9. |
69. |
Growth hormone deficiency and
replacement in patients with treated Cushing's Disease, prolactinomas and non-functioning
pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone
mineral density. Colson A, Brooke AM, Walker D, Besser GM, Chew SL, Grossman AB,
Jenkins PJ, Drake WM, Monson JP. Horm Res. 2006;66(6):257-67.
|
70. |
Cancers associated with
acromegaly. Jenkins PJ. Neuroendocrinology. 2006;83(3-4):218-23. |
71. |
The role of hormone
replacement therapy in healthy elderly men.
Jenkins PJ. Nat Clin Pract Urol. 2006 Sep;3(9):470-1.
|
72. |
Selective parathyroid venous
sampling in patients with complicated hyperparathyroidism. Ogilvie CM, Brown PL, Matson M,
Dacie J, Reznek RH, Britton K, Carpenter R, Berney D, Drake WM, Jenkins PJ, Chew
SL, Monson JP. Eur J Endocrinol. 2006 Dec;155(6):813-21. |
73. |
Unmasking of central
hypothyroidism following growth hormone replacement in adult hypopituitary patients. Agha A,
Walker D, Perry L, Drake WM, Chew SL, Jenkins PJ, Grossman AB, Monson JP. Clin
Endocrinol (Oxf). 2007 Jan;66(1):72-7. |
74. |
Role of fasting plasma
glucose, glycated haemoglobin and homeostatic model assessment in the detection of glucose
intolerance in adult hypopituitary patients during growth hormone replacement therapy.
Colson A, Walker D, Besser GM, Grossman AB, Chew SL, Jenkins PJ, Drake WM, Monson
JP. Hormone Research. 2008;69(2):83-8. |
75. |
The expression and function
of IGFBP-3 in normal and malignant breast tissue.
McCarthy K, Laban C, McVittie CJ, Ogunkolade W, Khalaf S, Bustin S, Carpenter R, Jenkins
PJ. Anticancer Research 2009 Oct;29(10):3785-90. |
76. |
Expression of
25-hydroxyvitamin D-1-alpha-hydroxylase, and vitamin D receptor mRNA in normal and malignant
breast tissue. McCarthy K, Laban C, Bustin SA, Ogunkolade W, Khalaf S, Carpenter R,
Jenkins PJ. Anticancer Research. 2009 Jan;29(1):155-7. |
77. |
A single-center open-label
study to investigate the efficacy and safety of repeated subcutaneous injections of lanreotide
Autogel in patients with acromegaly previously treated with octreotide. Kelly P, Maher KT,
Chew SL, Monson JP, Grossman AB, Jenkins PJ. Endocrine Practice 2010
Mar-Apr;16(2):191-7. |
78. |
Guidelines for colorectal
cancer screening and surveillance in moderate and high risk groups (update from 2002).
Cairns SR, Scholefield JH, Steele RJ, Dunlop MG, Thomas HJ, Evans GD, Eaden JA, Rutter MD, Atkin
WP, Saunders BP, Lucassen A, Jenkins P, Fairclough PD, Woodhouse CR; British
Society of Gastroenterology; Association of Coloproctology for Great Britain and Ireland. Gut.
2010 May;59(5):666-89. |
79. |
Repeated colonoscopic
screening of patients with acromegaly: 15 year experience identifies those at risk of new
colonic neoplasia and allows for effective screening guidelines. Dworakowska D, Gueorguiev
M, Kelly P, Monson J, Besser GM, Chew S, Akker S, Drake W, Fairclough P, Grossman A,
Jenkins P. European Journal of Endocrinology. 2010 Apr 30. |
80. |
Coronary artery calcification
progression in asymptomatic individuals with initial score of zero.
Koulaouzidis G, Charisopoulou D, Maffrett S, Tighe M, Jenkins PJ, McArthur T.
Angiology. 2013 Oct;64(7):494-7 2012 Sep 11.
|
81. |
Prevalence and distribution of coronary
artery calcification in asymptomatic British population.
Koulaouzidis G, Jenkins PJ, McArthur T.
Can J Cardiol. 2013 Jan;29(1):131. 2012 Nov 10..
|
82. |
Differences in clinical profile of
individuals with severe and markedly elevated coronary artery calcification detected by
electron beam computed tomography.
Koulaouzidis G, Charisopoulou D, Maffrett S, Tighe M, Jenkins PJ, McArthur T.
Angiology. 2013 Aug;64(6):435-9. 2012 Jul 26.
|
83. |
Aggressive and diffuse coronary
calcification in South Asian angina patients compared to Caucasians with similar risk
factors.
Koulaouzidis G, Nicoll R, Charisopoulou D, McArthur T, Jenkins PJ, Henein MY.
Int J Cardiol. 2013 Sep 10;167(6):2472-6 Epub 2012 Jun 16.
|
84. |
Prevalence of noncalcified coronary
plaque in patients with calcium score of 0: the silent enemy.
Koulaouzidis G, Charisopoulou D, Jenkins PJ, Koulaouzidis A, McArthur T.
Angiology. 2013 Apr;64(3):205-10. 2012 Apr 9.
|
|